NovaMed, Inc. (NASDQ:NOVA) has announced that it will speak at the 2010 Jefferies Global Healthcare Services Conference on Tuesday, January 26. NovaMed Chairman, President and Chief Executive Officer Thomas Hall, and Executive Vice President and Chief Financial Officer Scott Macomber will represent the company at 9:30 am ET in New York City. The presentation will conclude at 10:00 am ET. Those unable to attend the event may listen to a webcast of the presentation online at www.wsw.com/webcast/jeff40/nova/. The webcast will remain on the site as a replay following the conclusion of the event.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
NovaMed, Inc. is a health care services company and an owner and operator of ambulatory surgery centers (ASCs). Its primary focus is to acquire, develop and operate ASCs in joint ownership with physicians throughout the United States. As of March 15, 2009, the Company owns and operates 37 ASCs located in 19 states. As of March 15, 2009, 13 of its 37 ASCs offer surgical services in specialties other than ophthalmology. As of March 15, 2009, the Company owned a majority interest in 35 of its ASCs with the minority interests generally being held by physicians. In addition it also owns 100% of the equity interests in two of its ASCs. In August 2008, the Company acquired MDnetSolutions, a call center and marketing solutions company serving primarily the bariatric market.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
